Form D — Star Therapeutics LLC
0002088123-25-000001 · filed Oct 6, 2025
Offering
- Industry
- Other
- Exemptions
- 06b
- Total offering
- $124,999,974
- Total sold
- $124,999,974
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Star Therapeutics LLC
- CIK
- 2088123
- Entity
- Limited Liability Company
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 201 HASKINS WAY, 5TH FLOOR
SOUTH SAN FRANCISCO, CA 94080 - Phone
- 888-742-1338
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Adam Rosenthal · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Scott Robertson · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Gary Patou · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Amrit Nagpal · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Beth Seidenberg · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Carl Gordon · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Maha Katabi · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Nancy Stagliano · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Matthew Fust · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Jason Hafler · DirectorSouth San Francisco, CA Find on LinkedIn ↗
-
Sandip Panicker · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
-
Michelle Carpenter · Executive OfficerSouth San Francisco, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗